Author: Gary Glick

Gary D. Glick obtained his Ph.D. from Columbia University in 1988, studying organic chemistry under the direction of W. Clark Still. He then completed a National Institutes of Health postdoctoral fellowship at Harvard University where he studied bio-organic chemistry in the laboratory of Jeremy R. Knowles. In 1990, Dr. Glick started his career as a faculty member at the University of Michigan in Ann Arbor, where he is now the Werner E. Bachmann emeritus professor of chemistry. He still maintains an active lab focused on metabolic control in the immune system and the development of new drugs for the treatment of autoimmunity and cancer. Dr. Glick is the Co-Founder, President and CEO of Boston-based IFM Therapeutics, a biopharmaceutical company developing a portfolio of first-in-class small molecules targeting the innate immune system for the treatment of cancer and inflammatory disease. Prior to founding IFM, he founded Lycera Corp, a leading biopharmaceutical company developing novel small molecule immunodulators for autoimmune disorders such as rheumatoid arthritis. Dr. Glick’s research interests are in drug discovery and development for autoimmune diseases and cancer; chemical-induced apoptosis; nucleic acid structure, folding and recognition; and molecular recognition of nucleic acids by proteins. He has served and continues to serve on numerous boards and committees, including the Bioorganic & Natural Products Chemistry Study Section of the National Institutes of Health and the Scientific Advisory Board of the National Arthritis Foundation, Michigan Chapter. He serves on several editorial boards, is Editor-in-Chief of Biopolymers, a leading journal publishing in the areas of biochemistry and biophysics, and was recently a counselor to the American Chemical Society Division of Biological Chemistry. Dr. Glick’s scientific contributions have been recognized with a number of different awards including, an Arthritis Investigator Award from the National Arthritis Foundation, a Junior Faculty Research Award from the American Cancer Society, a Young Investigator Award from the National Science Foundation, a Camille Dreyfus Teacher-Scholar Award, a Research Fellowship from the Alfred P. Sloan Foundation, two Research Excellence Awards from the University of Michigan, and he is a Fellow of the American Association for the Advancement of Science.